ArticlePreventive medicine reports2020
The impact of e-cigarette and cigarette prices on e-cigarette and cigarette sales in California.
Article in Preventive medicine reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The impact of e-cigarette taxation: a systematic review and meta-analysis on usage, pricing strategies, and public health implications.BMC medicine · 2026Pooled it
- Global trends in e-cigarette regulatory compliance: A bibliometric analysis of policies and emerging challenges.Medicine · 2026Article
- How do US Adults Who Vape Choose Among Different E-Cigarette (EC) Models and Cigarettes in Response to Prices and Taxes.Health economics · 2026Article
- Electronic Smoking Devices Among University Students: Usage Patterns and Chemical Composition of Inhaled Substances.Analytical science advances · 2026Article
- The economic factors that determine smoking abstinence: a survival and mediation analysis.The International journal on drug policy · 2025Article
- Use of multiple devices among U.S. adults frequently using ENDS in 2023.Drug and alcohol dependence · 2025Article
- Article
- How do users compare the costs between nicotine vaping products and cigarettes? Findings from the 2016-2020 International Tobacco Control United States surveys.Addiction (Abingdon, England) · 2024Article
- Cumulative Exposure to E-Cigarette Coupons and Changes in E-Cigarette Use Among U.S. Adults.American journal of preventive medicine · 2024Article
- Will tobacco price increases lead more people who smoke to vape? The results from a discrete choice experiment amongst U.S. adults.BMC public health · 2023Article
- Socio-demographic Correlates of Electronic Cigarette and Cannabis Co-use Among Naïve and Tobacco Adolescent Users.Journal of prevention (2022) · 2023Article
- The Short-Term and Long-Term Associations Between Receiving Tobacco Discounts or Coupons and Smoking Cessation Among U.S. Adult Cigarette Smokers With Intention to Quit.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2023Article
- Consumption of JUUL vs. Other E-Cigarette Brands among U.S. E-Cigarette Users: Evidence from Wave 5 of the PATH Study.International journal of environmental research and public health · 2022Article
- Multiple Tobacco Product Use Conceptual Framework: A 2021 Update on Evidence.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2022Review
- News events and their relationship with US vape sales: an interrupted time series analysis.BMC public health · 2022Article
- The Association between E-Cigarette Price and TV Advertising and the Sales of Smokeless Tobacco Products in the USA.International journal of environmental research and public health · 2021Article
- E-Cigarettes: A New Threat to Cardiovascular Health - A World Heart Federation Policy Brief.Global heart · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Although numerous studies have examined the impact of cigarette prices on cigarette demand, research examining the impact of e-cigarette and cigarette prices on e-cigarette demand is relatively limited. This study estimated the impact of e-cigarette and cigarette prices on e-cigarette and cigarette sales in California. Using the 2012-2017 Nielsen Retail Scanner Data, we constructed e-cigarette prices, cigarette prices, and per capita e-cigarette and cigarette sales by year, quarter, and Nielsen scantrack market in California. E-cigarettes were categorized as disposable or reusable. Separate fixed-effects models estimated the impact of e-cigarette and cigarette prices on per capita disposable e-cigarette, reusable e-cigarette, and cigarette sales controlling for year, quarter, market, and smoke-free air law coverage. Average prices were $5.86 per pack of 20 cigarettes, $9.80 per disposable e-cigarette, and $19.11 per reusable e-cigarette. When prices of disposable e-cigarettes, reusable e-cigarettes, and cigarettes increased by 1%, per capita sales of the products decreased by 0.37%, 0.20%, and 0.21% respectively. Cigarette prices were positively associated with per capita sales of reusable e-cigarettes, indicating reusable e-cigarettes are substitutes for cigarettes. Reusable e-cigarette prices were positively associated with per capita sales of disposable e-cigarettes, indicating disposable e-cigarettes are substitutes for reusable e-cigarettes. No statistically significant association was found between disposable/reusable e-cigarette prices and cigarette sales. Our results suggest that raising prices of disposable e-cigarettes, reusable e-cigarettes, and cigarettes such as via tobacco excise tax increases would result in reduced sales for the products. Policymakers should consider the substitution between e-cigarettes and cigarettes when designing tobacco control policies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.